When does WELLGISTICS HEALTH INC (WGRX) report earnings?
WELLGISTICS HEALTH INC (WGRX) will report earnings on 2026-05-01.
WELLGISTICS HEALTH INC (WGRX) Forecast, Price Target & Analyst Ratings
NASDAQ:WGRX • US9495031067
Current stock price
0.144 USD
0 (-2.24%)
At close:
0.1391 USD
0 (-3.4%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for WELLGISTICS HEALTH INC (WGRX).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $0.14 to mean target of N/A, Based on analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
%
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 1, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 18.129M | 23.338M 28.73% | ||
| EBITDA YoY % growth | N/A | -5.03M | -77.984M -1,450.25% | |
| EBIT YoY % growth | -2.881M -54,250.94% | -6.145M -113.33% | -81.195M -1,221.29% | |
| Operating Margin | N/A | -33.90% | -347.91% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A